Page last updated: 2024-11-13

lassomycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

lassomycin: a ribosomally synthesized peptide that kills Mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2; amino acid sequence in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID102602724
MeSH IDM000602946

Synonyms (3)

Synonym
RS-2025
lassomycin (glrrlfadqlvgrrni)
lassomycin

Research Excerpts

Overview

Lassomycin is a highly basic, ribosomally encoded cyclic peptide. It has an unusual structural fold that only partially resembles that of other lasso peptides.

ExcerptReferenceRelevance
"Lassomycin is a highly basic, ribosomally encoded cyclic peptide with an unusual structural foldĀ that only partially resembles that of other lasso peptides."( Lassomycin, a ribosomally synthesized cyclic peptide, kills mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2.
Akopian, T; Bissell, A; Cao, S; Clardy, J; Epstein, S; Fetterman, A; Gavrish, E; Goldberg, A; Hughes, D; Kandror, O; Lewis, K; Ling, L; Mueller, A; Peoples, A; Sit, CS; Spoering, A; Torrey, H, 2014
)
2.57
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.96 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]